GENE ONLINE|News &
Opinion
Blog

Tyler Chen

"Never go to a doctor whose office plants have died."- Erma Bombeck

WRITTEN BY Tyler Chen

Japan’s Otsuka Inks $890M Deal with Sunovion to Target Neurological Illness
2021-10-01
Shionogi’s COVID-19 Oral Drug and Nasal Vaccine Makes Headway in Trials
2021-09-29
Astellas, Seagen Cancer Drug Becomes First and Only Approved ADC For Advanced Urothelial Cancer in Japan
2021-09-28
China Drugmaker Aims for First Generic Drug Approval of Novartis’ Tasigna in China
2021-09-24
Serum Institute of India Invests in UK Vaccine Maker to Produce More COVID-19 Vaccines
2021-09-23
Taiwan’s AMS BioteQ Develops a New Antimicrobial Dressing Which Accelerates Diabetes Wound Healing
2021-09-22
Japan’s Nippon Foundation Injects $210M into Osaka University’s 10-Year Infectious Diseases Research Plan
2021-09-15
MD Anderson to Develop Microbiome Cancer Therapeutics with CRISPR Gene-Editing
2021-09-14
Korea’s First Private-Led New Drug Cluster to Launch in Late September
2021-09-11
Innovent to Send the First-Ever SIRPa Targeting Antibody to Human Trials in China
2021-09-10
This Australian Biotech is Developing a Nanocellular COVID-19 Vaccine for the Immunocompromised
2021-09-09
China’s Sinopharm to Develop its First mRNA COVID-19 Vaccine
2021-09-07
Singapore Exchange to Allow SPAC Listings on the Mainboard
2021-09-03
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
Another Homegrown Anti-PD-1 Antibody Scores Regulatory Win in China
2021-08-31
1 2 3 4 9
Scroll to Top